Application of a newly developed ELISA for BCAR1 protein for prediction of clinical benefit of tamoxifen therapy in patients with advanced breast cancer.

Find Full text
Thumbnail
Fulltext:
58218.pdf
Embargo:
until further notice
Size:
76.20Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2004
Author(s)
Dorssers, L.C.
Grebenchtchikov, N.J.
Brinkman, A.B.
Look, M.P.
Klijn, J.G.M.
Geurts-Moespot, A.
Span, P.N.
Foekens, J.A.
Sweep, C.G.J.
Source
Clinical Chemistry, 50, 8, (2004), pp. 1445-7
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/58218   https://hdl.handle.net/2066/58218
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.